We are pleased to announce that the Director of our BRC, Professor Matt Brown, has been appointed to the role of Chief Scientific Officer at Genomics England.
Professor Brown will succeed Professor Sir Mark Caulfield in this important role which he will take up in November 2021. Professor Brown will be stepping down as Director of our BRC but will however retain affiliations with the Trust and King’s College London in order to continue his clinical and research activities.
Commenting on this appointment, Professor Charles Wolfe, Director of R&D at Guy’s and St Thomas’, said: “Congratulations to Matt on his appointment as Chief Scientific Officer at Genomics England, an important national role drawing on his experience and research interests in genomics. We wish him well in his new role and look forward to maintaining our collaborations with him at Genomics England. Matt has provided excellent leadership for the BRC since his appointment in 2019 and has overseen the BRC’s important contribution to Urgent Public Health studies in prevention and management of COVID-19.”
Professor Ajay Shah, Executive Dean, Faculty of Life Sciences and Medicine at King’s College London, commented: “We are very proud of Professor Brown’s appointment, in which he will lead on all scientific activities for Genomics England, including crucial projects looking at genome sequencing in rare disease, cancer and infection. Professor Brown will retain an important role at the university where he will continue to work on genomics related to conditions such as axial spondyloarthritis, a chronic back pain caused by inflammatory arthritis, and other important disease areas.”
Genomics England’s CEO Chris Wigley added: “We’re delighted Professor Matt Brown has accepted this position providing the benefit of his scientific expertise, leadership, and knowledge of the research landscape. Genomics England’s vision is a world in which everyone has access to the benefits of genomics healthcare, and Matt can help us deliver on that vision.”
Professor Brown said: “While I’m thrilled to be joining Genomic England and working with its staff to deliver on the promise genomics offers to improve diagnosis and management of human diseases, I am also sad to be leaving the NIHR Guy’s and St Thomas’ BRC. I am extremely proud of what we have achieved together as a BRC over the last two years, particularly our clinical and research contributions to the pandemic, and grateful to all colleagues and staff for their collaboration and support. I will really miss working with the many truly inspirational and dedicated researchers and staff associated with the BRC. I look forward to continuing many of those collaborations as I take up my new role.”
Interim arrangements for the BRC leadership will be communicated in due course.